Smith & Nephew plc vs Upstart Holdings Inc — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Upstart Holdings Inc trades at $29.34 (market cap $2.76B). The key difference: Smith & Nephew plc is far larger — about 4.6× Upstart Holdings Inc's market cap, and Smith & Nephew plc pays a 2.57% dividend while Upstart Holdings Inc pays none. Which is the better fit depends on your goals.
| SNN | UPST | |
|---|---|---|
Market Cap | $12.64B | $2.76B |
Sector | Health | Financials |
52-Week High | $38.70 | $84.13 |
52-Week Low | $28.73 | $24.22 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →